Evidence map›Paper›PMID 39359687›Full record

ArticleFrontiers in molecular neuroscience2024

CNPY2 protects against ER stress and is expressed by corticostriatal neurons together with CTIP2 in a mouse model of Huntington's disease.

Miriana Scordino, Polina Stepanova, Vignesh Srinivasan, Dan Duc Pham, Ove Eriksson, Maciej Lalowski, Giuseppa Mudò, Valentina Di Liberto, Laura Korhonen, Merja H Voutilainen and 1 more

Abstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Cnpy1 is a candidate endoplasmic reticulum chaperone of vomeronasal type 2 GPCRs.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Miriana ScordinoDepartment of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, Helsinki, Finland.
Polina StepanovaFaculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Vignesh SrinivasanDepartment of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, Helsinki, Finland.
Dan Duc PhamDepartment of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, Helsinki, Finland.
Ove ErikssonDepartment of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, Helsinki, Finland.
Maciej LalowskiMeilahti Clinical Proteomics Core Facility, HiLIFE, University of Helsinki, Helsinki, Finland.
Giuseppa MudòDepartment of Biomedicine, Neuroscience, and Advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.
Valentina Di LibertoDepartment of Biomedicine, Neuroscience, and Advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.
Laura KorhonenDepartment of Child and Adolescent Psychiatry, Linköping University, Linköping, Sweden.
Merja H VoutilainenFaculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Dan LindholmDepartment of Biochemistry and Developmental Biology, Medical Faculty, University of Helsinki, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canopy Homolog 2 (CNPY2) is an endoplasmic reticulum (ER) localized protein belonging to the CNPY gene family. We show here that CNPY2 is protective against ER stress induced by tunicamycin in neuronal cells. Overexpression of CNPY2 enhanced, while downregulation of CNPY2 using shRNA expression, reduced the viability of neuroblastoma cells after tunicamycin. Likewise, recombinant CNPY2 increased survival of cortical neurons in culture after ER stress. CNPY2 reduced the activating transcription factor 6 (ATF6) branch of ER stress and decreased the expression of CCAT/Enhancer-Binding Protein Homologous Protein (CHOP) involved in cell death. Immunostaining using mouse brain sections revealed that CNPY2 is expressed by cortical and striatal neurons and is co-expressed with the transcription factor, COUPTF-interacting protein 2 (CTIP2). In transgenic N171-82Q mice, as a model for Huntington's disease (HD), the number of CNPY2-immunopositive neurons was increased in the cortex together with CTIP2. In the striatum, however, the number of CNPY2 decreased at 19 weeks of age, representing a late-stage of pathology. Striatal cells in culture were shown to be more susceptible to ER stress after downregulation of CNPY2. These results demonstrate that CNPY2 is expressed by corticostriatal neurons involved in the regulation of movement. CNPY2 enhances neuronal survival by reducing ER stress and is a promising factor to consider in HD and possibly in other brain diseases.

Indexed as

CNPY2CTIP2ER stressHuntington’s diseasenerve cell viabilityUPR

Identifiers

PMID39359687
PMCPMC11446244

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.